SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-17-041337
Filing Date
2017-06-23
Accepted
2017-06-23 17:18:05
Documents
72
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A a17-15598_110qa.htm 10-Q/A 1123017
2 EX-31.1 a17-15598_1ex31d1.htm EX-31.1 9985
3 EX-31.2 a17-15598_1ex31d2.htm EX-31.2 9992
4 EX-32.1 a17-15598_1ex32d1.htm EX-32.1 6046
5 EX-32.2 a17-15598_1ex32d2.htm EX-32.2 6045
  Complete submission text file 0001104659-17-041337.txt   7792431

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jagx-20170331.xml EX-101.INS 1436778
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jagx-20170331.xsd EX-101.SCH 87064
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jagx-20170331_cal.xml EX-101.CAL 64082
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jagx-20170331_def.xml EX-101.DEF 361160
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT jagx-20170331_lab.xml EX-101.LAB 673103
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jagx-20170331_pre.xml EX-101.PRE 548089
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Animal Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36714 | Film No.: 17928419
SIC: 2834 Pharmaceutical Preparations